Separation and determination of selected psychotropic drugs in human serum by SPE/HPLC/DAD on C18 and Polar-RP columns

References

• Ghaemi, S. N. Ed. Polypharmacy in Psychiatry. New York, Marcel Dekker, 2002, pp. 35–150.
   Google Scholar
• Stewart, C. H. Hypnotics and Sedatives. In The Pharmacological Basis of Therapeutics, 7th ed. New York: Macmillan Publishing Company, 1985, pp. 339–371.
   Google Scholar
• Dowben, J. S., Grant, J. S., Froelich, K. D., Keltner, N. L. Hydroxyzine for Anxiety: Another Look at an Old Drug. Perspect. Psychiatr. Care. 2013, 49, 75–77.
   PubMed Web of Science ®Google Scholar
• MacQueen, G.; Born, L.; Steiner M. The Selective Serotonin Reuptake Inhibitor Sertraline: Its Profile and Use in Psychiatric Disorders. CNS Drug Rev. 2001, 7, 1–24.
   PubMedGoogle Scholar
• Sebaaly, J. C., Cox, S., Hughes, C. M., Kennedy, M. L. H., Garris, S. S. Use of Fluoxetine in Anorexia Nervosa Before and After Weight Restoration. Ann. Pharmacother. 2013, 47, 1201–1205.
   PubMed Web of Science ®Google Scholar
• Altamura, A. C., Moro, A. R., Percudani, M. Clinical Pharmacokinetics of Fluoxetine. Clin. Pharmacokin. 1994, 26, 201–214.
   PubMed Web of Science ®Google Scholar
• Hartung, B.; Wada, M.; Laux, G.; Leucht, S. Perphenazine for Schizophrenia. Cochrane Detabase Cochrane Db. Syst. Rev. 2005, 1005, 1, 1–98.
   Google Scholar
• Mulsant, B. H., Sweet, R. A., Rosen, J., Pollock, B. G., Zubenko, G. S., Flynn, T., Begley, A. E., Mazumdar, S., Reynolds, C. F., Cummings, J. A randomized double-blind comparison of nortriptyline plus placebo vs. nortriptyline plus perphenazine in the treatment of psychotic major depression in late life. Am. J. Geriatr. Psychiatry 1999, 7, 33.
   Google Scholar
• Wada, K.; Yamada, N.; Hamamura, T.; Suzuki, H.; Nakano, Y.; Kuroda, S. Add-On Polytherapy with Antidepressants and Its Significance in Inpatients with Major Depression. Psychiatry Clin. Neurosci. 1999, 53, 557–562.
   PubMed Web of Science ®Google Scholar
• Piergies, A. A., Sweet, J.; Johnson, J. M.; Roth-Schechter, B. F.; Allard, S. The Effect of Co-administration of Zolpidem with Fluoxetine: Pharmacokinetics and Pharmacodynamics. Int. J. Clin. Pharmacol. Therap. 1996, 34, 178–183.
   PubMed Web of Science ®Google Scholar
• Nelson, J. C. Combined Treatment Strategies in Psychiatry. J. Clin. Psychiatry 1993, 54, 42–49.
   PubMed Web of Science ®Google Scholar
• Sasaki, C.; Shinozuka, T.; Murakami, C.; Irie, W.; Maeda, K.; Watanabe, T.; Nakamaru, N.; Furukawa, M.; Nakamura, S.; Kurihara, K. Simultaneous Determination of 5 Psychotropic Drugs of Various Types in an Autopsy Case of Acute Multiple Drug Poisoning. Forensic Sci. Int. 2013, 227, 90–94.
   PubMed Web of Science ®Google Scholar
• Maya, M. T.; Domingos, C. R.; Guerreiro, M. T.; Morais, J. A. Determination of the Antidepressant Fluoxetine in Human Plasma by LC with UV Detection. J. Pharm. Biomed. Anal. 2000, 23, 989–996.
   PubMed Web of Science ®Google Scholar
• Tantawy, M. A.; Hassan, N. Y.; Elragehy, N. A.; Abdelkawy, M. Simultaneous Determination of Olanzapine and Fluoxetine Hydrochloride in Capsules by Spectrophotometry, TLC-Spectrodensitometry and HPLC. J. Adv. Res. 2013, 4, 173–180.
   PubMedGoogle Scholar
• Ring, P. R.; Bostick, J. M. Validation of a Method for the Determination of Zolpidem in Human Plasma Using LC with Fluorescence Detection. J. Pharm. Biomed. Anal. 2000, 22, 495–504.
   PubMed Web of Science ®Google Scholar
• Lucca, A.; Gentilini, G.; Lopez-Silva, S.; Soldarini, A. Simultaneous Determination of Human Plasma Levels of Four Selective Serotonin Reuptake Inhibitors by High-Performance Liquid Chromatography. Therap. Drug Monit. 2000, 22, 271–276.
   PubMed Web of Science ®Google Scholar
• Kirchherr, H.; Kuhn-Velten, W. N. Quantitative Determination of Forty-Eight Antidepressants and Antipsychotics in Human Serum by HPLC Tandem Mass Spectrometry: A Multi-level, Single-Sample Approach. J. Chromatogr. B 2006, 843, 100–113.
   PubMed Web of Science ®Google Scholar
• Urinovska, R.; Brozmanova, H.; Sistik, P.; Silhan, P.; Kacirova, I.; Lemr, K.; Grundmann, M. Liquid Chromatography–Tandem Mass Spectrometry Method for Determination of Five Antidepressants and Four Atypical Antipsychotics and Their Main Metabolites in Human Serum. J. Chromatogr. B 2012, 907, 101–107.
   PubMed Web of Science ®Google Scholar
• Vecchione, G.; Casetta, B.; Chiapparino, A.; Bertolino, A.; Tomaiuolo, M.; Cappuccia, F.; Gatta, R.; Margaglione, M.; Grandone, E. A Reliable and Rapid Tool for Plasma Quantification of 18 Psychotropic Drugs by ESI Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2012, 67–68, 104–113.
   PubMed Web of Science ®Google Scholar
• Rohrig, T. P.; Prouty, R. W. Fluoxetine Overdose: A Case Report. J. Anal. Toxicol. 1989, 13, 305–307.
   PubMed Web of Science ®Google Scholar
• Labata, L.; Deveauxb, M.; Dalleta, P.; Dubosta, J. P. Separation of New Antidepressants and Their Metabolites by Micellar Electrokinetic Capillary Chromatography. J. Chromatogr. B 2002, 773, 17–23.
   PubMed Web of Science ®Google Scholar
• Mut, L.; Grobosch, T.; Binscheck-Domaß, T.; Frenzel, W. Toxicological Screening of Human Plasma by On-line SPE-HPLC-DAD: Identification and Quantification of Basic Drugs and Metabolites. Biomed. Chromatogr. 2014, 29, 935–952.
   PubMed Web of Science ®Google Scholar
• Sabbioni, C.; Bugamelli, F.; Varani, G.; Mercolini, L.; Musengaa, A.; Saracino, M. A.; Fanali, S.; Raggi, M. A. A Rapid HPLC-DAD Method for the Analysis of Fluoxetine and Norfluoxetine in Plasma from Overdose Patients. J. Pharm. Biomed. Anal. 2004, 36, 351–356.
   PubMed Web of Science ®Google Scholar
• Silva, B. J. G.; Queiroz, R. H. C.; Queiroz, M. E. C. Simultaneous Determination of Nontricyclic Antidepressants in Human Plasma by Solid-Phase Microextraction and Liquid Chromatography (SPME-LC). J. Anal. Toxicol. 2007, 31, 313–320.
   PubMed Web of Science ®Google Scholar
• Tournel, G.; Houdret, N.; Hedouin, V.; Deveaux, M.; Gosset, D.; Lhermitte, M. High-Performance Liquid Chromatographic Method to Screen and Quantitate Seven Selective Serotonin Reuptake Inhibitors in Human Serum. J. Chromatogr. B 2001, 761, 147–158.
   PubMed Web of Science ®Google Scholar
• Cutroneo, P.; Beljean, M.; Phan Tan Luu, R.; Siouffi, A.-M. Optimization of the Separation of Some Psychotropic Drugs and Their Respective Metabolites by Liquid Chromatography. J. Pharm. Biomed. Anal. 2006, 41, 333–340.
   PubMed Web of Science ®Google Scholar
• Kaliszan, R.; Marszałł, M. P.; Markuszewski, M. J.; Bączek, T.; Pernak, J. Suppression of Deleterious Effects of Free Silanols in Liquid Chromatography by Imidazolium Tetrafluoroborate Ionic Liquids. J. Chromatogr. A 2004, 1030, 263–271.
   PubMed Web of Science ®Google Scholar
• Fernandez-Navarro, J. J.; Garcia-Alvarez-Coque, M. C.; Ruiz-Angel, M. J. The Role of the Dual Nature of Ionic Liquids in the Reversed-Phase Liquid Chromatographic Separation of Basic Drugs. J. Chromatogr. A 2011, 1218, 398–407.
   PubMed Web of Science ®Google Scholar
• Nawrocki, J. The Review Silanol Group and Its Role in Liquid Chromatography. J. Chromatogr. A 1997, 779, 29–71.
   Web of Science ®Google Scholar
• Reubsaet, J. L. E.; Vieskar, R. Characterisation of π–π Interactions Which Determine Retention of Aromatic Compounds in Reversed-Phase Liquid Chromatography. J. Chromatogr. A 1999, 841, 147–154.
   Web of Science ®Google Scholar
• Euerby, M. R.; Petersson, P.; Campbell, W.; Roe, W. Chromatographic Classification and Comparison of Commercially Available Reversed-Phase Liquid Chromatographic Columns Containing Phenyl Moieties Using Principal Component Analysis. J. Chromatogr. A 2007, 1154, 138–151.
   PubMed Web of Science ®Google Scholar
• Euerby, M. R.; Petersson, P. Chromatographic Classification and Comparison of Commercially Available Reversed-Phase Liquid Chromatographic Columns Using Principal Component Analysis. J. Chromatogr. A 2003, 994, 13–36.
   PubMed Web of Science ®Google Scholar
• Kayillo, S.; Dennis, G. R.; Shalliker, R. A. An Assessment of the Retention Behaviour of Polycyclic Aromatic Hydrocarbons on Reversed Phase Stationary Phases: Selectivity and Retention on C18 and Phenyl-Type Surfaces. J. Chromatogr. A 2006, 1126, 283–297.
   PubMed Web of Science ®Google Scholar
• Petruczynik, A.; Wróblewski, K.; Dzioba, K.; Waksmundzka-Hajnos, M. Retention, Separation Selectivity and System Efficiency of Selected Basic Psychotropic Drugs on Different RPLC Columns. Open Chemistry 2015, 13, 943–950.
   Web of Science ®Google Scholar
• Petruczynik, A.; Wróblewski, K.; Szultka-Młyńska, M.; Buszewski, B.; Karakuła-Juchnowicz, H.; Gajewski, J.; Morylowska-Topolska, J.; Waksmundzka-Hajnos, M. Determination of Some Psychotropic Drugs in Serum and Saliva Samples by HPLC-DAD and HPLC-MS. J. Pharm. Biomed. Anal. 2016, 127, 68–80.
   PubMed Web of Science ®Google Scholar
• Petruczynik, A.; Wróblewski, K.; Waksmundzka-Hajnos, M. Comparison of Chromatographic Conditions for Analysis of Selected Psychotropic Drugs in Human Serum. J. Chromatogr. Sci. 2015, 53, 394–400.
   PubMed Web of Science ®Google Scholar
• Baczek, T.; Kaliszan, R.; Novotna, K.; Jandera, P. Comparative Characteristics of HPLC Columns Based on Quantitative Structure–Retention Relationships (QSRR) and Hydrophobic-Subtraction Mode. J. Chromatogr. A 2005, 1075, 109–115.
   PubMed Web of Science ®Google Scholar
• Franceschi, L.; Faggiani, A.; Furlanut, M. A Simple Method to Monitor Serum Concentrations of Fluoxetine and Its Major Metabolite for Pharmacokinetic Studies. J. Pharm. Biomed. Anal. 2009, 49, 554–557.
   PubMed Web of Science ®Google Scholar
• Fernandes, C.; dos Santos Neto, A. J.; Rodrigues, J. C.; Alves, C.; Lancas F. M. Solid-Phase Microextraction–Liquid Chromatography (SPME–LC) Determination of Fluoxetine and Norfluoxetine in Plasma Using a Heated Liquid Flow through Interface. J. Chromatogr. B 2007, 847, 217–223.
   PubMed Web of Science ®Google Scholar
• Ansermot, N.; Brawand-Ameya, M.; Eap, C. B. Simultaneous Quantification of Selective Serotonin Reuptake Inhibitors and Metabolites in Human Plasma by Liquid Chromatography–Electrospray Mass Spectrometry for Therapeutic Drug Monitoring. J. Chromatogr. B 2012, 885–886, 117–130.
   PubMed Web of Science ®Google Scholar
• Chen, F.; Gong, Z.; Kelly, B. C. Rapid Analysis of Pharmaceuticals and Personal Care Products in Fish Plasma Micro-aliquots Using Liquid Chromatography Tandem Mass Spectrometry. J. Chromatogr. A 2015, 1383, 104–111.
   PubMed Web of Science ®Google Scholar
• Sheng-Liu Y., Xiao-Feng, L., Xiao-Man, J., Hai-Xia, Z., Shao-Kui, Z. Simultaneous Determination of 13 Psychiatric Pharmaceuticals in Sewage by Automated Solid Phase Extraction and Liquid Chromatography-Mass Spectrometry. Chin. J. Anal. Chem. 2013, 41, 49–56.
   Google Scholar
• Pedernera, C.; Ruiz, J. L.; Castells, G.; Manteca, X.; Cristofol, C. HPLC Quantification of Perphenazine in Sheep Plasma: Application to a Pharmacokinetic Study. J. Chromatogr. B 2007, 854, 308–312.
   PubMed Web of Science ®Google Scholar
• Eliassen, E.; Kristoffersen, L. Quantitative Determination of Zopiclone and Zolpidem in Whole Blood by Liquid–Liquid Extraction and UHPLC-MS/MS. J. Chromatogr. B 2014, 971, 72–80.
   PubMed Web of Science ®Google Scholar
• European Pharmacopoeia, 8th ed. Strasbourg, France: Council of Europe, 2013.
   Google Scholar
• Schulz, M.; Schmoldt, A. Therapeutic and Toxic Blood Concentrations of More Than 800 Drugs and Other Xenobiotics. Pharmazie, 2003, 58, 447–474.
   PubMed Web of Science ®Google Scholar